LexDanaLexDanabeta
Inventor

CHRISTIAN KLEIN

Inventor
CH

Overview

84→
Patents
2021–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 84 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary
C07KPeptides26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
A61KPreparations for medical, dental or toiletry purposes25%
G06FElectric digital data processing7%
C12NMicroorganisms or enzymes4%
G09GArrangements or circuits for control of indicating devices using static means to present variable information3%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
G06VImage or video recognition or understanding1%
G09FDisplaying1%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
PatentTitleYear
12,565,530Combination therapy with targeted 4-1BB (CD137) agonists/anti-FAP binding domain and anti-CEA/anti-CD3 bispecific antibody202612,441,812Methods of treating cancer by administering tumor necrosis factor (TNF) family ligand trimer-containing antigen-binding molecules202512,419,862Use of a cathepsin s inhibitor against the formation of anti-drug antibodies202512,391,757Bispecific antibodies specific for PD1 and TIM3202512,358,997Bispecific anti-human A-beta/anti-human transferrin receptor antibodies202512,345,711Methods to determine antibody activity in tumor samples202512,331,134Trispecific antibodies specific for HER2 and a blood brain barrier receptor and methods of use202512,291,561Antigen binding receptors specific for mutated Fc domains202512,286,486Anti-FAP antibodies and methods of use202512,281,153Combination therapy with targeted 4-1BB (CD137) agonists202512,275,794Bispecific antigen binding molecules comprising anti-FAP clone 212202512,240,911Bispecific antibodies specific for OX40202512,227,594Bispecific 2+1 contorsbodies202512,215,155Antibodies binding to CD3 and CD19202512,202,870Antigen binding molecules comprising a trimeric TNF family ligand and encoding polynucleotides thereof202512,186,392Combination therapy of an anti CD20 antibody with a BTK inhibitor202512,145,994Bispecific antigen binding molecules capable of specific binding to CD40 and to fap202412,139,553T cell activating bispecific antigen binding molecules202412,103,982T cell activating bispecific antigen binding molecules202412,105,950Extensions to global keyboard shortcuts for computing devices having multiple display regions202412,098,213Antibodies binding to HLA-A2/WT1202412,079,464Predictive gesture optimizations for moving objects across display boundaries202412,073,066User interface transitions and optimizations for foldable computing devices202412,073,067User interface transitions and optimizations for foldable computing devices202412,065,478HER2-targeting antigen binding molecules comprising 4-1BBL202412,049,515Agonistic CD28 antigen binding molecules targeting Her2202412,038,441CAR-T reporter based diagnostic assays to detect tumor antigens in cancer patients202412,030,952Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use202412,030,946Therapeutic and diagnostic methods for cancer202412,023,368Immunoconjugates202412,000,064Universal reporter cell assay for specificity test of novel antigen binding moieties202411,993,642Trivalent, bispecific antibodies202411,987,632Antibodies binding to HLA-A2/MAGE-A4202411,952,421Bispecific antibodies against CD3EPSILON and ROR1202411,915,671Eye gaze control of magnification user interface202411,865,082Combination therapy of PD-1-targeted IL-2 variant immunocytokines and antibodies against human PD-L1202411,827,711Antibodies binding to NKG2D202311,809,702Modeless augmentations to a virtual trackpad on a multiple screen computing device202311,788,205Car-t cell assay for specificity test of novel antigen binding moieties202311,787,873Bispecific HER2 antibodies and methods of use202311,787,868Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use202311,780,920Antibodies binding to CD3 and CD19202311,780,919Bispecific antigen binding molecules targeting OX40 and FAP202311,740,914Positioning user interface components based on application layout and user workflows202311,732,052Bispecific antibody molecules with antigen-transfected T-cells and their use in medicine202311,718,680Combination therapy of anti-CD20/anti-CD3 bispecific antibodies and 4-1BB (CD137) agonists202311,679,127Antigen binding receptors specific for mutated Fc domains202311,673,945Bispecific antigen binding proteins202311,669,164Augmenting the functionality of user input devices using a digital glove202311,639,397Bispecific antibodies specific for T-cell activating antigens and a tumor antigen and methods of use202311,639,394Bispecific antigen binding molecule for a costimulatory TNF receptor202311,613,587Combination therapy of T cell activating bispecific antigen binding molecules and PD-1 axis binding antagonists202311,608,376Tumor-targeted agonistic CD28 antigen binding molecules202311,603,411Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use202311,590,128Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor202311,583,575MHC-bound peptide arrays and methods of use thereof202311,547,748Adoptive t-cell therapy202311,525,007Antibody fab and Fc variants202211,513,122Predicting response to PD-1 axis inhibitors202211,459,404Bispecific T cell activating antigen binding molecules202211,453,722Bispecific antigen binding molecule for a costimulatory TNF receptor202211,449,295Interchangeable device components202211,447,558Bispecific antigen binding molecules comprising anti-4-1BB clone 20H4.9202211,442,621Extensions to global keyboard shortcuts for computing devices having multiple display regions202211,430,414Eye gaze control of magnification user interface202211,413,331Immunoconjugates202211,413,282Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor202211,365,232Interleukin-2 fusion proteins and uses thereof202211,332,545Anti-FAP antibodies and methods of use202211,314,409Modeless augmentations to a virtual trackpad on a multiple screen computing device202211,306,154Methods of treating cancer by administering antigen-binding molecules comprising a TNF family ligand trimer202211,294,463Augmenting the functionality of user input devices using a digital glove202211,285,207Bispecific antibodies specifically binding to PD1 and LAG3202211,267,903Antigen-binding molecules comprising a tumor necrosis factor (TNF) family ligand trimer202211,242,390Protease-activated T cell bispecific molecules202211,242,396Bispecific antigen binding molecules comprising anti-FAP clone 212202211,221,759Transitions and optimizations for a foldable computing device operating in a productivity mode202211,214,622Antibodies specific for DR5 and methods of use202211,200,072User interface adaptations based on inferred content occlusion and user intent202111,199,901Augmenting the functionality of non-digital objects using a digital glove202111,192,957Antibodies binding to HLA-A2/WT1202111,149,083Antigen binding molecules comprising a TNF family ligand trimer and a Tenascin binding moiety202111,138,912Dynamic screen modes on a bendable computing device202111,137,905Modeless augmentations to a virtual trackpad on a multiple screen computing device2021

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2021–2026Patents assigned to HOFFMANN LA ROCHE (59)· patent assignee history
2021–2024Patents assigned to MICROSOFT TECHNOLOGY LICENSING LLC (18)· patent assignee history
2021–2026Based in CH· patent location history
2021–2024Based in US· patent location history
2022–2025Patents assigned to ROCHE GLYCART AG (6)· patent assignee history
2022–2023Patents assigned to ABBVIE INC (2)· patent assignee history
2022–2023Patents assigned to GENENTECH INC (2)· patent assignee history
2022–2024Based in DE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
HOFFMANN LA ROCHE592021–2026
MICROSOFT TECHNOLOGY LICENSING LLC182021–2024
ROCHE GLYCART AG62022–2025
ABBVIE INC22022–2023
GENENTECH INC22022–2023
Locations
LocationPatentsSpan
CH632021–2026
US182021–2024
DE32022–2024